Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study

BACKGROUND: Inhaled corticosteroids (ICS) are a prevailing treatment option for COPD patients but recent guidelines have relegated their use predominantly to patients with frequent exacerbations. Yet large numbers of patients worldwide are currently treated with ICS-containing regimens. We wished to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bloom, Chloe I, Douglas, Ian, Usmani, Omar S, Quint, Jennifer K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136662/
https://www.ncbi.nlm.nih.gov/pubmed/32308379
http://dx.doi.org/10.2147/COPD.S241568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136662/
https://www.ncbi.nlm.nih.gov/pubmed/32308379
http://dx.doi.org/10.2147/COPD.S241568

Ejemplares similares